MABVAX THERAPEUTICS HOLDINGS, INC.: 10-Q filed 2018-11-13

Name: MABVAX THERAPEUTICS HOLDINGS, INC.: 10-Q filed 2018-11-13
Creator: MABVAX THERAPEUTICS HOLDINGS, INC.

What MABVAX THERAPEUTICS HOLDINGS, INC. reported in its quarterly report filed 2018-11-13 (fiscal Q3 2018): 36 published measures, 103 facts as tagged in accession 0001654954-18-012555.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-11-13
Fiscal period: fiscal Q3 2018
Accession: 0001654954-18-012555 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MABVAX THERAPEUTICS HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-09-30	8,897,260	USD
At 2017-12-31	8,790,324	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-09-30	8,854,702	USD
At 2017-12-31	7,659,884	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-09-30	42,558	USD
At 2017-12-31	1,130,440	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-09-30	951,751	USD
At 2017-12-31	885,710	USD
At 2017-09-30	3,052,778	USD
At 2016-12-31	3,979,290	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	340,681	USD	92
2018-01-01 to 2018-09-30	-5,908,068	USD	273
2017-07-01 to 2017-09-30	-3,080,161	USD	92
2017-01-01 to 2017-09-30	-14,424,883	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	0	USD	273
2017-01-01 to 2017-09-30	21,072	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	4,000,000	USD	92
2018-01-01 to 2018-09-30	4,700,000	USD	273
2017-07-01 to 2017-09-30	0	USD	92
2017-01-01 to 2017-09-30	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-09-30	-118,349,884	USD
At 2017-12-31	-111,053,637	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	9,253,880	shares	92
2018-01-01 to 2018-09-30	8,983,980	shares	273
2017-07-01 to 2017-09-30	3,830,280	shares	92
2017-01-01 to 2017-09-30	2,834,692	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	17,123,742	shares	92
2018-01-01 to 2018-09-30	8,983,980	shares	273
2017-07-01 to 2017-09-30	3,830,280	shares	92
2017-01-01 to 2017-09-30	2,834,692	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	0.04	USD/shares	92
2018-01-01 to 2018-09-30	-0.81	USD/shares	273
2017-07-01 to 2017-09-30	-1.62	USD/shares	92
2017-01-01 to 2017-09-30	-8.04	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	0.02	USD/shares	92
2018-01-01 to 2018-09-30	-0.81	USD/shares	273
2017-07-01 to 2017-09-30	-1.62	USD/shares	92
2017-01-01 to 2017-09-30	-8.04	USD/shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-09-30	457,526	USD
At 2017-12-31	578,206	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	1,307,162	USD	273
2017-01-01 to 2017-09-30	4,516,372	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	494,683	USD	92
2018-01-01 to 2018-09-30	-5,410,200	USD	273
2017-07-01 to 2017-09-30	-2,848,690	USD	92
2017-01-01 to 2017-09-30	-13,681,746	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-09-30	1,435,134	USD
At 2017-12-31	1,207,518	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	94,755	USD	92
2018-01-01 to 2018-09-30	308,271	USD	273
2017-07-01 to 2017-09-30	138,642	USD	92
2017-01-01 to 2017-09-30	445,934	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-09-30	7,769,378	USD
At 2017-12-31	5,806,266	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-09-30	2,447,175	USD
At 2017-12-31	1,090,904	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-09-30	6,826,003	USD
At 2017-12-31	6,826,003	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,720,317	USD	92
2018-01-01 to 2018-09-30	9,325,200	USD	273
2017-07-01 to 2017-09-30	2,848,690	USD	92
2017-01-01 to 2017-09-30	13,581,746	USD	273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	3,215,000	USD	92
2018-01-01 to 2018-09-30	3,915,000	USD	273
2017-07-01 to 2017-09-30	0	USD	92
2017-01-01 to 2017-09-30	0	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	785,000	USD	92
2018-01-01 to 2018-09-30	785,000	USD	273
2017-07-01 to 2017-09-30	0	USD	92
2017-01-01 to 2017-09-30	0	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	199,367	USD	92
2018-01-01 to 2018-09-30	2,915,709	USD	273
2017-07-01 to 2017-09-30	1,017,061	USD	92
2017-01-01 to 2017-09-30	6,168,125	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-09-30	9,254,582	shares
At 2017-12-31	6,862,928	shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2018-09-30	2,814,126	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-09-30	178,597	USD
At 2017-12-31	178,597	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-09-30	240,781	USD
At 2017-12-31	186,278	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-09-30	2,106,295	USD
At 2017-12-31	1,669,201	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	340,681	USD	92
2018-01-01 to 2018-09-30	-7,296,247	USD	273
2017-07-01 to 2017-09-30	-6,200,161	USD	92
2017-01-01 to 2017-09-30	-22,784,296	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,520,950	USD	92
2018-01-01 to 2018-09-30	6,409,491	USD	273
2017-07-01 to 2017-09-30	1,831,629	USD	92
2017-01-01 to 2017-09-30	7,513,621	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	120,680	USD	273
2017-01-01 to 2017-09-30	122,315	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-154,002	USD	92
2018-01-01 to 2018-09-30	-497,868	USD	273
2017-07-01 to 2017-09-30	-231,471	USD	92
2017-01-01 to 2017-09-30	-743,137	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	317,391	USD	273
2017-01-01 to 2017-09-30	302,256	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	0	USD	273
2017-01-01 to 2017-09-30	125,000	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	1,356,273	USD	273
2017-01-01 to 2017-09-30	403,210	USD	273

Inspect the source

Entity: MABVAX THERAPEUTICS HOLDINGS, INC. / CIK 0001109196
Captured: 2026-09-22 19:41 UTC
SEC response SHA-256: 2dc5df2a7df3f38f707cc55c9468803a1fe6d3f0a8c8a7e3bdc387c99f005336

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001109196.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))